Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis
Espasa, M.; Salvadó, M.; Vicente, E.; Tudó, G.; Alcaide, F.; Coll, P.; Martin-Casabona, N.; Torra, M.; Fontanals, D.; González-Martín, J.
Journal of Clinical Microbiology 50(2): 488-491
The aim of this study was to evaluate the reliability of the VersaTREK system for Mycobacterium tuberculosis drug susceptibility testing compared with results obtained with the Bactec MGIT 960 system. A total of 67 strains were evaluated. Overall agreement was at 98.5%. Kappa indexes were 1.0 for isoniazid, rifampin, and ethambutol, 0.937 for pyrazinamide, and 0.907 for streptomycin. The VersaTREK system is validated for M. tuberculosis drug susceptibility testing.